PodcastIntel
Sign in Get Started Free
HCPLive
HCPLive

Finerenone’s Efficacy in HF Unaffected by Concomitant CKM Components

Sep 16, 2026 · 0:11:02
✨ AI Summary
  • Finerenone's efficacy and safety in heart failure are unaffected by cardio-kidney-metabolic conditions.
  • Secondary analysis of FINEARTS-HF presented at ESC Congress 2026.
  • Finerenone is effective across diverse patient profiles with HF.

Guests on This Episode

JO
John Ostrominski
1 podcast appearance

More from HCPLive

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to HCPLive and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →